AtriCure Inc

ATRC

Company Profile

  • Business description

    AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

  • Contact

    7555 Innovation Way
    MasonOH45040
    USA

    T: +1 513 755-4100

    E: [email protected]

    https://www.atricure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    1,350

Stocks News & Analysis

stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.
stocks

This might be the best core stock bargain in the US market today

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.
stocks

Data center demand drives strong earnings outlook for SGM

Sims guides huge earnings upgrade as data center metals demand spikes.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,552.6077.000.91%
CAC 407,507.44158.18-2.06%
DAX 4021,890.63489.56-2.19%
Dow JONES (US)45,577.47443.96-0.96%
FTSE 1009,712.80205.53-2.07%
HKSE24,382.47894.85-3.54%
NASDAQ21,647.61443.08-2.01%
Nikkei 22551,515.491,857.04-3.48%
NZX 50 Index12,899.7290.27-0.69%
S&P 5006,506.48100.01-1.51%
S&P/ASX 2008,365.9082.400.99%
SSE Composite Index3,813.28143.77-3.63%

Market Movers